CDK4/6 inhibitors in breast cancer

[21]

[21]. Our study highlighted the limitations of the immunofluorescence assay (IFA) using viral capsid antigen (VCA) and early antigen (EA) in patients under 30 years of age. and 30 years old,p< 0.01; 1529 and 30 years old,p< 0.05). …